Drug Pipeline

rezatapopt Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT04585750 The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C… Advanced Solid Tumor Recruiting
Phase 1
NCT06616636 A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C… Myelodysplastic Syndrome Recruiting
NCT07372625 A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the… TP53 Y220C Mutation Recruiting
Sponsors Running rezatapopt Trials
PMV Pharmaceuticals, Inc (2) M.D. Anderson Cancer Center (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Small Cell Lung Cancer (1) Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) HER2-Positive Breast Cancer (1) Prostate Cancer (1) Colorectal Cancer (1) Bladder Cancer (1) Ovarian Cancer (1)
Get alerts when rezatapopt trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free